Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models

Neurodegenerative diseases are characterized by distinct patterns of neuronal loss. In amyotrophic lateral sclerosis (ALS) upper and lower motoneurons degenerate whereas in Huntington’s disease (HD) medium spiny neurons in the striatum are preferentially affected. Despite these differences the patho...

Full description

Bibliographic Details
Main Authors:	Eva Buck, Hanna Bayer, Katrin S. Lindenberg, Johannes Hanselmann, Noemi Pasquarelli, Albert C. Ludolph, Patrick Weydt, Anke Witting
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-05-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	amyotrophic lateral sclerosis Huntington’s disease Sirt3 PGC-1α mitochondria SOD(G93A)
Online Access:	http://journal.frontiersin.org/article/10.3389/fnmol.2017.00156/full

Similar Items

ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues
by: Hanna Bayer, et al.
Published: (2017-01-01)

SIRT1 Interacts with Prepro-Orexin in the Hypothalamus in SOD1G93A Mice
by: Gan Zhang, et al.
Published: (2022-04-01)

Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats
by: Rinske Vlamings, et al.
Published: (2012-12-01)

Microglia Morphological Changes in the Motor Cortex of hSOD1<sup>G93A</sup> Transgenic ALS Mice
by: Sara Migliarini, et al.
Published: (2021-06-01)

Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan
by: Laura Moreno-Martinez, et al.
Published: (2022-11-01)

Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice
by: Claudia Figueroa-Romero, et al.
Published: (2020-02-01)

Myricanol rescues dexamethasone‐induced muscle dysfunction via a sirtuin 1‐dependent mechanism
by: Shengnan Shen, et al.
Published: (2019-04-01)

Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model
by: Laura Moreno-Martinez, et al.
Published: (2020-05-01)

Assessment of Immunological Potential of Glial Restricted Progenitor Graft In Vivo—Is Immunosuppression Mandatory?
by: Urszula Kozlowska, et al.
Published: (2021-07-01)

Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
by: Laura Moreno-Martínez, et al.
Published: (2019-04-01)

Protective effects of intrathecal injection of AAV9-RabGGTB-GFP+ in SOD1G93A mice
by: Tianchu Gao, et al.
Published: (2023-03-01)

Endothelin-1, over-expressed in SOD1G93A mice, aggravates injury of NSC34-hSOD1G93A cells through complicated molecular mechanism revealed by quantitative proteomics analysis
by: Yingzhen Zhang, et al.
Published: (2022-12-01)

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
by: Laura Rué, et al.
Published: (2019-07-01)

Drosophila expressing human SOD1 successfully recapitulates mitochondrial phenotypic features of familial Amyotrophic Lateral Sclerosis
by: Gallart-Palau, Xavier, et al.
Published: (2016)

Assessing neuraxial microstructural changes in a transgenic mouse model of early stage Amyotrophic Lateral Sclerosis by ultra‐high field MRI and diffusion tensor metrics
by: Rodolfo G. Gatto, et al.
Published: (2020-06-01)

Mitochondrial Sirtuins in Reproduction
by: Giovanna Di Emidio, et al.
Published: (2021-06-01)

N-acetyl-l-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model
by: Wei Li, et al.
Published: (2015-08-01)

NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis
by: Biying Yang, et al.
Published: (2023-08-01)

CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
by: Maria Chiara Trolese, et al.
Published: (2020-12-01)

Molecular mechanisms involved in the pathogenesis of Huntington's disease /
by: 506084 Perandones, Claudia, et al.
Published: (c201)

Sirtuins as Players in the Signal Transduction of <i>Citrus</i> Flavonoids
by: Giovanni Enrico Lombardo, et al.
Published: (2024-02-01)

The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
by: Natalia Nowicka, et al.
Published: (2022-02-01)

Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease
by: Ido Rippin, et al.
Published: (2021-07-01)

Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis
by: Silvia Scaricamazza, et al.
Published: (2024-03-01)

LncRNAs Associated with Neuronal Development and Oncogenesis Are Deregulated in SOD1-G93A Murine Model of Amyotrophic Lateral Sclerosis
by: Federica Rey, et al.
Published: (2021-07-01)

Melittin restores proteasome function in an animal model of ALS
by: Lee Sang Min, et al.
Published: (2011-06-01)

Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice
by: Núria Gaja-Capdevila, et al.
Published: (2021-12-01)

Downregulation of Neuronal and Dendritic Connexin36-Made Electrical Synapses Without Glutamatergic Axon Terminals in Spinal Anterior Horn Cells From the Early Stage of Amyotrophic Lateral Sclerosis
by: Yuko Kobayakawa, et al.
Published: (2018-11-01)

Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System
by: Haofuzi Zhang, et al.
Published: (2023-04-01)

Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
by: Barbara Poletti, et al.
Published: (2022-11-01)

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
by: Sofia Bergh, et al.
Published: (2022-09-01)

The Effect of Eight Weeks of Water Training on Sirt1, Pgc-1α and Body Fat Percentage in Obese Men
by: M Soltani, et al.
Published: (2018-09-01)

MRI findings in juvenile Huntington's disease
by: Patrick Arraj, BS, et al.
Published: (2021-01-01)

FM19G11-loaded nanoparticles modulate energetic status and production of reactive oxygen species in myoblasts from ALS mice
by: Claudia Malacarne, et al.
Published: (2024-04-01)

A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation
by: Antonio Vallarola, et al.
Published: (2020-11-01)

Progressive Mitochondrial SOD1<sup>G93A</sup> Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral Sclerosis
by: Iago Méndez-López, et al.
Published: (2021-07-01)

Sympathetic neuropathology is revealed in muscles affected by amyotrophic lateral sclerosis
by: Antonio Mazzaro, et al.
Published: (2023-05-01)

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
by: Albert J. B. Lee, et al.
Published: (2023-01-01)

Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
by: Cinzia Volonté, et al.
Published: (2020-07-01)

Satellite Glial Cells of the Dorsal Root Ganglion: A New “Guest/Physiopathological Target” in ALS
by: María Ruiz-Soto, et al.
Published: (2020-11-01)